Common Medications Can Worsen Fatty Liver, Specialists Warn

Specialists from the Hepatology Service at Hospital Clínic de Barcelona and the MSD Manual warn that everyday medications can worsen fatty liver disease or trigger fat accumulation in the organ even in people without other risk factors such as obesity or diabetes.

The list of drugs under medical surveillance includes paracetamol (acetaminophen), corticosteroids, certain anti-epileptics, antibiotics, synthetic estrogens, antiretrovirals, tamoxifen, amiodarone, methotrexate, tetracyclines, antidepressants and antihypertensives. The impact depends on dose, treatment duration and the presence of other conditions, the sources said.

Paracetamol, sold over the counter, is identified by the MSD Manual as the leading cause of drug-induced liver injury worldwide. Its metabolism occurs almost entirely in the liver; when consumed in excess, the organ produces a toxic compound called NAPQI (N-acetyl-p-benzoquinoneimine) that is normally neutralized by glutathione, a natural antioxidant. If the dose exceeds the liver’s capacity to neutralize that compound, NAPQI damages liver cells and can lead to necrosis or, in severe cases, acute liver failure.

The maximum recommended daily dose for adults is 4,000 milligrams. In people with fatty liver, exceeding that limit or combining the drug with alcohol or other hepatotoxic medications increases the risk of toxicity. The MSD Manual places paracetamol alongside non-steroidal anti-inflammatory drugs (NSAIDs) as the analgesic group with the greatest potential for liver damage.

Doctors Isabel Graupera Garcia-Milà and Pere Ginès Gibert, along with nurse Marta Cervera Carbonell, all from the Hepatology Service at Hospital Clínic de Barcelona, said certain pharmacological treatments can generate fatty liver as a side effect even without other risk factors present, according to infobae.

These cases are classified as non-alcoholic fatty liver disease of secondary cause. According to the Clínic team, the treatments most associated with this condition include:

Hospital Clínic de Barcelona opened its doors on December 22, 1906, with a capacity of 400 patients transferred from Hospital de la Santa Creu.

It serves as the university hospital for the University of Barcelona Faculty of Medicine, combining healthcare with teaching and research through the August Pi i Sunyer Biomedical Research Institute. The hospital functions as both a community provider for a population of 540,000 and a tertiary center for complex cases nationally and internationally.

  • Corticosteroids, which alter fat and carbohydrate metabolism and promote hepatic fat deposition, especially with prolonged use or high doses.
  • Synthetic estrogens, present in oral contraceptives, which interfere with normal lipid metabolism.
  • Antiretrovirals, used in HIV treatment, which can cause mitochondrial toxicity and alter fatty acid oxidation.
  • Tamoxifen, used in breast cancer, with the capacity to alter hepatic fat metabolism during prolonged treatments.
  • Amiodarone, an antiarrhythmic that accumulates in the liver and affects lipid metabolism.
  • Methotrexate, used in cancer and autoimmune diseases, with documented direct hepatotoxicity.
  • Tetracyclines, antibiotics that can alter hepatic lipid synthesis and secretion.

The MSD Manual expands this list with other frequently used drugs: anti-epileptics such as carbamazepine, phenobarbital, phenytoin and valproate; antidepressants such as bupropion, fluoxetine and sertraline; antihypertensives such as captopril, enalapril and losartan; and antibiotics such as amoxicillin with clavulanic acid, clindamycin and erythromycin.

Photo of author

Health Desk

Health Desk at Archyde.

Kospi, Nasdaq Drop Over 5%; Blind Users Post Heavy Losses